Abiopharma

Bodenstedt Matthias 🟢 acquired 354.3K shares of MoonLake Immunotherapeutics (MLTX) Transaction Date: Jan 07, 2026 | Filing ID: 002907

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

📋 Kaye Jack (Director) plans to sell 6K shares of uniQure N.V. (at $27.28 each, total $174K) Filed: Jan 09, 2026 | ID: 000004

Notification from CorMedix Inc.

WE26 Call for Participation for Breakout Sessions Now Open!

📋 Laponis Adam (Officer) plans to sell 3K shares of Twist Bioscience Corp (at $35.26 each, total $97K) Filed: Jan 09, 2026 | ID: 000242

📋 TAHL CINDY (Officer) plans to sell 11K shares of FATE THERAPEUTICS INC (at $1.06 each, total $11K) Filed: Jan 09, 2026 | ID: 000240

📋 Valamehr Bahram (Officer) plans to sell 5K shares of FATE THERAPEUTICS INC (at $1.07 each, total $6K) Filed: Jan 09, 2026 | ID: 000239

China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering

Assertio Holdings, Inc. - Assertio Announces Publication ofRolvedon® Same-Day Dosing Clinical Trial

Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial

IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results

New Form SCHEDULE 13G/A - Mersana Therapeutics, Inc. Filed: 2026-01-09 AccNo: 0001916761-26-000002 Size: 14 KB

(19% Negative) Heron Therapeutics, Inc. (HRTX) Announces Delay in portfolio Development Timeline Due to Regulatory Process, Safety Review, Efficacy Assessment

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)